CA
NZ
UK
AU
IND
US
Impinj, Inc. filed a current report on Form 8-K on September 10, 2026, disclosing that it entered into privately-negotiated exchange agreements to retire approximately $56.3 million in aggregate principal amount of its outstanding 1.125% Convertible Senior Notes due 2027.
Park Hotels & Resorts Inc. filed a current report on Form 8-K on September 11, 2026, disclosing the departure of Thomas C. Morey, Executive Vice President and Chief Investment Officer, effective September 8, 2026.
Citi Trends, Inc. filed a Form 8-K with the SEC on September 11, 2026, disclosing that Heather Plutino, Executive Vice President, Chief Financial Officer and Chief Accounting Officer, notified the company on September 10, 2026 of her decision to step down for personal reasons.
Exelixis, Inc. filed a Form 8-K on September 11, 2026, disclosing that the FDA extended the review period for its new drug application for zanzalintinib in combination with atezolizumab by three months, moving the action date to March 3, 2027.
Oklo Inc. filed a Form 8-K with the SEC on September 11, 2026, disclosing entry into a new equity distribution agreement allowing the company to sell up to $1,000,000,000 in Class A common stock through an at-the-market program, while simultaneously terminating a prior agreement …
Alcoa Corporation (NYSE:AA) filed a current report on September 11, 2026, disclosing that South32 Limited released a notice of meeting and explanatory memorandum on September 10, 2026 (Australian Western Standard Time), convening a shareholder vote on the proposed sale of South32's bauxite, alumina, and …
Opus Genetics, Inc. filed a Form 8-K on September 11, 2026, furnishing a revised data presentation that corrects an error in visual acuity reporting from Cohort 1 of its Phase 1/2 clinical trial of OPGx-BEST1 in patients with BEST1-related retinal diseases.
Gentherm Incorporated filed a Form 8-K on September 11, 2026, reporting the results of a special shareholder meeting held on September 10, 2026, at which shareholders approved two key proposals related to a Reverse Morris Trust transaction with Modine Manufacturing Company.
Lithium Americas Corp. filed an 8-K on September 11, 2026, disclosing that Vice President of Corporate Development Alexi Zawadzki notified the board of his intention to retire, effective September 11, 2026.
AtaiBeckley Inc. filed a Form 8-K with the SEC on September 11, 2026, reporting the completion of its merger with Eli Lilly and Company, under which AtaiBeckley became a wholly owned subsidiary of Eli Lilly.
Please wait processing your request...